Zobrazeno 1 - 10 of 1 829 pro vyhledávání: '"Gold HS"'
1
Akademický článek
Fluoroquinolone Prescribing for Diabetic Foot Infections following an FDA Drug Safety Communication for Aortic Aneurysm Risk.
Autor: Li C; Department of Pharmacy, Beth Israel Deaconess Medical Centergrid.239395.7, Boston, Massachusetts, USA., Mercuro NJ; Department of Pharmacy, Beth Israel Deaconess Medical Centergrid.239395.7, Boston, Massachusetts, USA., Chapin RW; Department of Pharmacy, Beth Israel Deaconess Medical Centergrid.239395.7, Boston, Massachusetts, USA., Gold HS; Division of Infectious Diseases, Beth Israel Deaconess Medical Centergrid.239395.7, Harvard Medical School, Boston, Massachusetts, USA.; Silverman Institute for Health Care Quality and Safety, Beth Israel Deaconess Medical Centergrid.239395.7, Boston, Massachusetts, USA., McCoy C; Department of Pharmacy, Beth Israel Deaconess Medical Centergrid.239395.7, Boston, Massachusetts, USA.
Publikováno v: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2021 Aug 17; Vol. 65 (9), pp. e0070821. Date of Electronic Publication: 2021 Aug 17.
Zobrazit plný text záznamu
2
Akademický článek
Diminishing returns, increasing risks: Impact of antibiotic duration of therapy on respiratory bacterial isolates in hospitalized patients during the coronavirus disease 2019 (COVID-19) pandemic.
Autor: Li C; Department of Pharmacy, Beth Israel Deaconess Medical Center, Boston, Massachusetts., Chapin RW; Department of Pharmacy, Beth Israel Deaconess Medical Center, Boston, Massachusetts., Mercuro NJ; Department of Pharmacy, Beth Israel Deaconess Medical Center, Boston, Massachusetts., Yen CF; Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts., Gold HS; Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.; Silverman Institute for Health Care Quality and Safety, Beth Israel Deaconess Medical Center, Boston, Massachusetts., Lee MSL; Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.; Silverman Institute for Health Care Quality and Safety, Beth Israel Deaconess Medical Center, Boston, Massachusetts., McCoy C; Department of Pharmacy, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
Publikováno v: Antimicrobial stewardship & healthcare epidemiology : ASHE [Antimicrob Steward Healthc Epidemiol] 2021 Jul 23; Vol. 1 (1), pp. e13. Date of Electronic Publication: 2021 Jul 23 (Print Publication: 2021).
Zobrazit plný text záznamu
3
Akademický článek
Synergistic potential of Leu10-teixobactin and cefepime against multidrug-resistant Staphylococcus aureus.
Autor: Koh, Augustine Jing Jie1,2,3 (AUTHOR), Hussein, Maytham1,2 (AUTHOR), Thombare, Varsha2 (AUTHOR), Crawford, Simon4 (AUTHOR), Li, Jian3 (AUTHOR) jian.li@monash.edu, Velkov, Tony1,2 (AUTHOR) tony.velkov@monash.edu
Publikováno v: BMC Microbiology. 10/29/2024, Vol. 24 Issue 1, p1-11. 11p.
Zobrazit plný text záznamu
4
Akademický článek
QT Interval in Patients With COVID-19-Reply.
Autor: Yen CF; Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts., Shim DJ; Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts., Gold HS; Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
Publikováno v: JAMA cardiology [JAMA Cardiol] 2021 Mar 01; Vol. 6 (3), pp. 358.
Zobrazit plný text záznamu
5
Akademický článek
Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19).
Autor: Mercuro NJ; Department of Pharmacy, Beth Israel Deaconess Medical Center, Boston, Massachusetts., Yen CF; Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts., Shim DJ; Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts., Maher TR; Harvard-Thorndike Electrophysiology Institute, Division of Cardiovascular Medicine, Beth Israel Deaconess Medical, Boston, Massachusetts., McCoy CM; Department of Pharmacy, Beth Israel Deaconess Medical Center, Boston, Massachusetts., Zimetbaum PJ; Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.; Harvard-Thorndike Electrophysiology Institute, Division of Cardiovascular Medicine, Beth Israel Deaconess Medical, Boston, Massachusetts., Gold HS; Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
Publikováno v: JAMA cardiology [JAMA Cardiol] 2020 Sep 01; Vol. 5 (9), pp. 1036-1041.
Zobrazit plný text záznamu
6
Report
Successful treatment of fulminant Clostridioides difficile infection with emergent fecal microbiota transplantation in a patient with acute myeloid leukemia and prolonged, severe neutropenia.
Autor: Lee MSL; Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Ramakrishna B; OpenBiome, Cambridge, MA, USA., Moss AC; Harvard Medical School, Boston, MA, USA.; Division of Gastroenterology, Hepatology, and Nutrition, Beth Israel Deaconess Medical Center, Boston, MA, USA., Gold HS; Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Branch-Elliman W; Harvard Medical School, Boston, MA, USA.; Department of Medicine, VA Boston Healthcare System, Boston, MA, USA.
Publikováno v: Transplant infectious disease : an official journal of the Transplantation Society [Transpl Infect Dis] 2020 Feb; Vol. 22 (1), pp. e13216. Date of Electronic Publication: 2019 Dec 17.
Zobrazit plný text záznamu
7
Akademický článek
Resistance to linezolid in Staphylococcus aureus by mutation, modification, and acquisition of genes.
Autor: Yang W; Center of Infectious Diseases and Pathogen Biology, The First Hospital of Jilin University, Changchun, China.; Department of Laboratory Medicine, The First Hospital of Jilin University, Changchun, China., Chen T; Center of Infectious Diseases and Pathogen Biology, The First Hospital of Jilin University, Changchun, China.; Department of Laboratory Medicine, The First Hospital of Jilin University, Changchun, China., Zhou Q; Department of Pediatrics, The First Hospital of Jilin University, Changchun, China., Xu J; Center of Infectious Diseases and Pathogen Biology, The First Hospital of Jilin University, Changchun, China. xjc@jlu.edu.cn.; Department of Laboratory Medicine, The First Hospital of Jilin University, Changchun, China. xjc@jlu.edu.cn.
Publikováno v: The Journal of antibiotics [J Antibiot (Tokyo)] 2024 Oct 17. Date of Electronic Publication: 2024 Oct 17.
Zobrazit plný text záznamu
8
Akademický článek
Fortifying transplantation Advancing infection prevention strategies for optimal outcomes.
Autor: Fajar, J. K.1 gembyok@gmail.com, Suwito, H.1, Mazen, M.1, Widiaputro, D. P.1, Rahardja, K. A.1, Pratama, E. J.1, Risqiansyah, C.1, Firmansah, W.1, Pramudia, D.1, Wattimuri, R. B.1, Gersom, C.1, Candradikusuma, D.2
Publikováno v: Archives of Hellenic Medicine / Arheia Ellenikes Iatrikes. Sep/Oct2024, Vol. 41 Issue 5, p588-598. 11p.
Zobrazit plný text záznamu
9
Akademický článek
Facility type and surgical specialty are associated with suboptimal surgical antimicrobial prophylaxis practice patterns: a multi-center, retrospective cohort study.
Autor: Branch-Elliman W; 1Department of Medicine, Section of Infectious Diseases, VA Boston Healthcare System, MA 1400 VFW Parkway West Roxbury, Boston, MA 02132 USA.; 2Center for Healthcare Organization and Implementation Research (CHOIR), VA Boston, Healthcare System, 150 South Huntington Avenue, Boston, MA 02130 USA.; 3Harvard Medical School, 25 Shattuck Street Boston, Boston, MA 02115 USA., Pizer SD; 4Partnered Evidence-based Policy Resource Center (PEPReC), Department of Veterans Affairs, 150 South Huntington Avenue Boston, Boston, MA 02130 USA.; 5Department of Health Law, Policy and Management, Boston University School of Public Health, 715 Albany Street, Boston, MA 02118 USA., Dasinger EA; VA Quality Scholars Program, Birmingham VA Medical Center, Birmingham, 700 19th Street S, AL 35233 England., Gold HS; 3Harvard Medical School, 25 Shattuck Street Boston, Boston, MA 02115 USA.; 7Beth Israel Deaconess Medical Center, Division of Infectious Diseases, 110 Francis Street, Boston, MA 02115 USA., Abdulkerim H; 2Center for Healthcare Organization and Implementation Research (CHOIR), VA Boston, Healthcare System, 150 South Huntington Avenue, Boston, MA 02130 USA., Rosen AK; 2Center for Healthcare Organization and Implementation Research (CHOIR), VA Boston, Healthcare System, 150 South Huntington Avenue, Boston, MA 02130 USA.; 8Department of Surgery, Boston University School of Medicine, 88 East Newton Street, C515, Boston, MA 02118 USA., Charns MP; 2Center for Healthcare Organization and Implementation Research (CHOIR), VA Boston, Healthcare System, 150 South Huntington Avenue, Boston, MA 02130 USA., Hawn MT; 9Palo Alto VA Medical Center, 3801 Miranda Ave, Palo Alto, CA 95010 USA.; 10Stanford University School of Medicine, 291 Campus Drive Stanford, Stanford, CA 94305 USA., Itani KMF; 11Department of Surgery, VA Boston Healthcare System, 1400 VFW Parkway West Roxbury, Boston, MA 02132 USA.; 3Harvard Medical School, 25 Shattuck Street Boston, Boston, MA 02115 USA.; 8Department of Surgery, Boston University School of Medicine, 88 East Newton Street, C515, Boston, MA 02118 USA., Mull HJ; 2Center for Healthcare Organization and Implementation Research (CHOIR), VA Boston, Healthcare System, 150 South Huntington Avenue, Boston, MA 02130 USA.; 8Department of Surgery, Boston University School of Medicine, 88 East Newton Street, C515, Boston, MA 02118 USA.
Publikováno v: Antimicrobial resistance and infection control [Antimicrob Resist Infect Control] 2019 Mar 06; Vol. 8, pp. 49. Date of Electronic Publication: 2019 Mar 06 (Print Publication: 2019).
Zobrazit plný text záznamu
10
Akademický článek
Clinical characteristics and treatment outcomes among respiratory syncytial virus (RSV)-infected hematologic malignancy and hematopoietic stem cell transplant recipients receiving palivizumab.
Autor: Permpalung N; a Department of Medicine , Beth Israel Deaconess Medical Center and Harvard Medical School , Boston , MA , USA., Mahoney MV; b Department of Pharmacy , Beth Israel Deaconess Medical Center , Boston , MA , USA., McCoy C; b Department of Pharmacy , Beth Israel Deaconess Medical Center , Boston , MA , USA., Atsawarungruangkit A; a Department of Medicine , Beth Israel Deaconess Medical Center and Harvard Medical School , Boston , MA , USA., Gold HS; a Department of Medicine , Beth Israel Deaconess Medical Center and Harvard Medical School , Boston , MA , USA., Levine JD; a Department of Medicine , Beth Israel Deaconess Medical Center and Harvard Medical School , Boston , MA , USA., Wong MT; c Merck Research Labs , North Wales , PA , USA., LaSalvia MT; a Department of Medicine , Beth Israel Deaconess Medical Center and Harvard Medical School , Boston , MA , USA., Alonso CD; a Department of Medicine , Beth Israel Deaconess Medical Center and Harvard Medical School , Boston , MA , USA.
Publikováno v: Leukemia & lymphoma [Leuk Lymphoma] 2019 Jan; Vol. 60 (1), pp. 85-91. Date of Electronic Publication: 2018 Jun 27.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje